Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors

AUTOR(ES)

Lu, Q. Richard

FONTE

The National Academy of Sciences

RESUMO

The most common primary tumors of the human brain are thought to be of glial cell origin. However, glial cell neoplasms cannot be fully classified by cellular morphology or with conventional markers for astrocytes, oligodendrocytes, or their progenitors. Recent insights into central nervous system tumorigenesis suggest that novel molecular markers might be found among factors that have roles in glial development. Oligodendrocyte lineage genes (Olig1/2) encode basic helix–loop–helix transcription factors. In the rodent central nervous system, they are expressed exclusively in oligodendrocytes and oligodendrocyte progenitors, and Olig1 can promote formation of an chondroitin sulfate proteoglycon-positive glial progenitor. Here we show that human OLIG genes are expressed strongly in oligodendroglioma, contrasting absent or low expression in astrocytoma. Our data provide evidence that neoplastic cells of oligodendroglioma resemble oligodendrocytes or their progenitor cells and may derive from cells of this lineage. They further suggest the diagnostic potential of OLIG markers to augment identification of oligodendroglial tumors.

Documentos Relacionados

• Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors
• Human brain glial cells synthesize thrombospondin.
• Antigen receptor genes as molecular markers of lymphoid neoplasms.
• Mutations in p53 as potential molecular markers for human breast cancer.
• Molecular signatures of cell cycle transcripts in the pathogenesis of Glial tumors